03Feb/14

Pharmacyclics, Inc. (PCYC) news: Pharmacyclics: Facts Behind $10B Market Cap – Seeking Alpha

Pharmacyclics, Inc. (PCYC) news: Pharmacyclics: Facts Behind $10B Market Cap
Seeking Alpha
To date, first-line treatment has usually consisted of Roche’s (OTCQX:RHHBY) monoclonal antibody Rituxan (rituximab) – which is directed against the CD20 antigen found on B lymphocytes – combined with a multi-agent chemotherapy regimen, most often